Assessing how healthy babies are when they start moving less than normal (FEMINA2)
-
Authors list
Dr Lucy Higgins, Prof Alexander Heazell, Dr Edward Johnstone, Dr Mark Wareing, Professor Colin Sibley
-
Research centre
This study is now completed
Feeling her baby move is one of the simplest ways of a mother being aware of her baby’s wellbeing. If a baby starts moving less than normal, this can be the first sign of a problem with the placenta, and there may be a significant risk of stillbirth. The FEMINA2 study looked at 300 women whose babies’ movements had decreased to develop a new way of finding which babies are at risk.
Women are advised to be aware of their baby’s movements and to go to a maternity unit if they notice their baby start moving less. We know that in women whose babies start moving less, the placenta is often smaller and less healthy, stopping it from giving the baby the food and oxygen it needs. We think that the baby stops moving as a survival strategy: they can save energy when food and oxygen are in short supply.
Many women attend maternity services for this reason in the last 12 weeks of pregnancy, however around three-quarters continue to have healthy pregnancies. At the moment there is no accurate way to tell which women have babies that are at risk of growth restriction or stillbirth. Doctors need to know this as early as possible in case the baby is struggling and needs to be delivered: a test is urgently needed to find babies at risk.
For each woman in the study, we collected 187 different pieces of information, many relating to the structure and function of the placenta.
We were then able to see which of these were related to pregnancy complications such as growth restriction, stillbirth, and admission to the neonatal intensive care unit. Using this information, we have developed a test based on ultrasound and blood tests that could find 30% more babies with at risk than our current standard tests.
We are continuing to test this in another group of women – the FEMINA3 group – in our PAPPO study.
Research papers
- Higgins LE, Johnstone ED, Heazell AEP. Management of Reduced Fetal Movements Fetal and Maternal Medicine Review 2013; 24(4):201-231.
- Higgins LE, Sibley CP, Wareing M, Johnstone ED, Heazell AEP. Umbilical Artery PI/RI Fail to Detect Aberrant Placental Arterial Function in Reduced Fetal Movement Pregnancies. Reproductive Sciences 2014;21(3 Suppl):182A.
- Higgins LE, Johnstone ED, Wareing M, Sibley CP, Heazell AEP. Identifying the Placental Phenotype of adverse pregnancy outcome: Potential novel biomarkers of the at-risk pregnancy. Baby Survival Conference, Amsterdam, 2014.
- Higgins LE, Johnstone ED, Wareing M, Sibley CP, Heazell AEP. Placental arterial Doppler surveillance in pregnancy can distinguish normal from abnormal placental vascular structure. Baby Survival Conference, Amsterdam 2014.
- Higgins LE, Johnstone ED, Wareing M, Sibley CP, Heazell AEP. Identifying the Placental Phenotype of Adverse Pregnancy Outcome: Potential Novel Biomarkers of the At-Risk Pregnancy. Fetal Growth, Oxford, 2014.
- Higgins LE, Johnstone ED, Wareing M, Sibley CP, Heazell AEP. Placental circulation arterial Doppler resistance is higher in fetal growth restriction. Blair Bell Research Society, London, 2013.
- Third trimester placental biometry is biologically accurate and relevant. Blair Bell Research Society, London, 2013
- Placental assessment aids identification of pregnancies with RFM experiencing adverse pregnancy outcome. BJOG 2015;122(S2):8-17 PPP.4
- Placental assessment aids identification of pregnancies with RFM experiencing adverse pregnancy outcome. Blair Bell Research Society, London, 2015. In Press; BJOG 2015
- Placental features of Late-onset adverse pregnancy outcome. PLoS ONE 2015;10(6):e0129117.
- Maternal perception of fetal movements in late pregnancy is affected by type and duration of fetal movements. J Matern Fetal Neonatal Med 2015 (epub ahead of print).
Timescale: 2011-2015
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news. If you're interested in being kept updated about our research and news from Tommy's, click here.
This study took place in a Tommy's centre and was funded by Tommy's and Action Medical Research
Read more on this topic
-
Research into stillbirth
When a baby dies after 24 weeks of gestation, it is called a stillbirth. Nearly 3000 families a year get the devastating news that their baby is not alive. Our research is helping to change this. -
Diabetes, fetal growth and stillbirth
Women suffering from type 1 or type 2 diabetes are more likely to suffer from stillbirths. We want to help people with diabetes to have healthy pregnancies. -
Preventing stillbirth: the role of the immune system in rejecting the placenta
Tommy’s are studying chronic histiocytic intervillositis, which causes the immune system to reject the placenta, leading to stillbirth or miscarriage. -
Can low levels of taurine make stillbirth more likely?
Tommy’s researchers are looking at how the lack of an important nutrient might harm the placenta during pregnancy, putting women at a higher risk of stillbirth. -
Understanding how the womb lining matures during pre-eclampsia
Pre-eclampsia can lead to health problems and sometimes stillbirth, but we don’t know enough about what causes it. Our researchers are studying how the lining of the womb develops during early pregnancy. This could reveal new ways to prevent pre-eclampsia and reduce the risk of stillbirth. -
The AFFIRM trial for prevention of stillbirth
Researchers supported by Tommy’s are looking at whether a package of care and resources for pregnant women can help stop stillbirths. -
Homing peptides: targeting drugs to the placenta
Drugs which could help prevent pregnancy complications can’t reach the placenta effectively. Tommy’s researchers are making use of ‘homing peptides’ to deliver drugs directly to the placenta. This work could help to prevent pregnancy complications and stillbirth. -
Stillbirth and fetal free haemoglobin
Researchers supported by Tommy’s have found that the substance that usually carries oxygen around our blood may have harmful effects on the baby when it escapes from red blood cells. -
ReMIT-2 – a feasibility study for spotting the early signs of complications
We need better ways to spot the early signs of pregnancy complications. The ReMIT-2 study laid the foundations for a large clinical trial of a blood test which could predict which women need urgent care to prevent stillbirth. -
Can steroid injections improve blood flow to babies at risk of stillbirth?
Finding out whether steroids can improve the blood flow through the placenta -
Older mothers and the ageing placenta
Consistent with ageing, the placenta in older mothers does not work as effectively. Researchers supported by Tommy’s are investigating why this happens. -
Comparing 2D and 3D MRI to study the placenta
Our scientists are developing new ways to use MRI scans to study the placenta, so that we can understand how it works and how its structure and function change during pregnancy. This will help us prevent complications like stillbirth and miscarriage.